組織名
(NC名) |
PMID |
掲載年
(Year.) |
論文名、演題名等 |
著者、発表者等 |
掲載誌、学会等 |
| NCC |
39948701 |
2025 |
Single-Nucleus RNA Sequencing and Spatial Transcriptomics for Squamous Cell Carcinoma Arising From Ovarian Mature Teratoma. |
Yoshida K, Yokoi A, Suzuki H, Tamauchi S, Kitagawa M, Inami E, Nakayama J, Mori Y, Okamoto K, et al. |
Cancer Sci. 2025 Feb 13. doi: 10.1111/cas.70022. Online ahead of print. |
| NCC |
39373493 |
2024 |
Tumor thickness is associated with metastasis in patients with submucosal invasive adenocarcinoma of the esophagogastric junction. |
Minakata N, Kadota T, Sakashita S, Inaba A, Sunakawa H, Takashima K, Nakajo K, Murano T, Shinmura K, et al. |
Dis Esophagus. 2024 Oct 7:doae083. doi: 10.1093/dote/doae083. Online ahead of print. |
| NCC |
39327855 |
2024 |
Inflammatory spindle cell PEComa of thelung with YAP1::TFE3 fusion: a report of two cases and a potential relationshipwith clear cell stromal tumour. |
Kojima N, Nishino S, Sasahara Y, Taki T, Imada H, Miyoshi T, Watanabe SI,Ishii G, Yatabe Y, et al. |
Histopathology. 2024 Sep 26. doi:10.1111/his.15328. Epub ahead of print. PMID: 39327855. |
| NCC |
39307824 |
2024 |
Association between pathological T1 colorectal cancer with lymphoid follicular replacement and risk of lymph node metastasis. |
Inaba A, Ikematsu H, Kojima M, Sakamoto N, Wakabayashi M, Sunakawa H, Nakajo K, Murano T, Kadota T, et al. |
J Gastroenterol Hepatol. 2024 Sep 22. doi: 10.1111/jgh.16745. Online ahead of print. |
| NCC |
39303401 |
2024 |
Association between lorlatinib blood concentration and adverse events and clinical impact of dose modification. |
Shimoda Igawa Y, Yoshida T, Makihara R, Torasawa M, Tateishi A, Matsumoto Y, Shinno Y, Okuma Y, Goto Y, et al. |
Lung Cancer. 2024 Sep 12;196:107954. |
| NCC |
39267678 |
2024 |
Prognostic significance of the FSTL1-DIP2A axis in early-stage tongue cancer. |
Chie Kudo-Saito, Satoko Matsumura, Taisuke Mori, Yoshitaka Honma, Seiichi Yoshimoto. |
American Journal of Cancer Research 14:3816-3825, 2024. |
| NCC |
39226222 |
2024 |
A novel histopathological feature of spatial tumor-stroma distribution predicts lung squamous cell carcinoma prognosis. |
Taki T, Koike Y, Adachi M, Sakashita S, Sakamoto N, Kojima M, Aokage K, Ishikawa S, Tsuboi M, et al. |
Cancer Sci. 2024 Sep 3. doi: 10.1111/cas.16244. Online ahead of print. |
| NCC |
39225725 |
2024 |
Quantification of Gremlin 1 throughout the tumor stroma using whole slide imaging and its clinicopathological significance in gastric cancer. |
Kitaoka T, Harada K, Sakashita S, Kojima M, Taki T, Kuwata T, Kinoshita T, Futakuchi M, Ishii G, et al. |
Virchows Arch. 2024 Sep 3. doi: 10.1007/s00428-024-03903-8. Online ahead of print. |
| NCC |
39199592 |
2024 |
Utility of Transpapillary Biopsy and Endoscopic Ultrasound-GuidedTissue Acquisition for Comprehensive Genome Profiling of Unresectable BiliaryTract Cancer. |
Fukuda S, Hijioka S, Nagashio Y, Yamashige D, Agarie D, Hagiwara Y, OkamotoK, Yagi S, Komori Y, et al. |
Cancers (Basel). 2024 Aug 10;16(16):2819. doi:10.3390/cancers16162819. PMID: 39199592; PMCID: PMC11353131. |
| NCC |
39191063 |
2024 |
Excellent concordance of the molecular classification between preoperative biopsy and final hysterectomy in endometrial carcinoma. |
Kato MK, Fujii E, Yamaguchi M, Higuchi D, Asami Y, Hiranuma K, Komatsu M, Hamamoto R, Matumoto K, et al. |
Gynecol Oncol.2024 Aug 26;190:139-145. |
| NCC |
39178372 |
2024 |
Treatment Decision for Locally Resected T1 Colorectal Carcinoma-Verification of the Japanese Guideline Criteria for Additional Surgery Based on Long-Term |
Oka S, Tanaka S, Kajiwara Y, Saito S, Fukunaga Y, Takamatsu M, Kawachi H, Hotta K, Ikematsu H, et al. |
Am J Gastroenterol. 2024 Oct 1;119(10):2019-2027. doi: 10.14309/ajg.0000000000002715. Epub 2024 Feb 12 |
| NCC |
39159053 |
2024 |
Predicting lymph node recurrence in cT1-2N0 tongue squamous cell carcinoma: collaboration between artificial intelligence and pathologists. |
Adachi M, Taki T, Kojima M, Sakamoto N, Matsuura K, Hayashi R, Tabuchi K, Ishikawa S, Ishii G, et al. |
J Pathol Clin Res. 2024 Sep;10(5):e12392. doi: 10.1002/2056-4538.12392. |
| NCC |
39141076 |
2024 |
Clinicopathological and prognostic features of HER2-null and HER2-low advancedbreast cancer treated with eribulin or capecitabine. |
Kitadai R, Shimoi T, Yazaki S, Okuma HS, Hoshino M, Ito M, Saito A, Kita S,Kojima Y, et al. |
Breast Cancer. 2024 Aug 14.doi: 10.1007/s12282-024-01617-y. Epub ahead of print. PMID: 39141076. |
| NCC |
39102634 |
2024 |
TrastuzumabDeruxtecan in Human Epidermal Growth Factor Receptor 2-Expressing Biliary TractCancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial. |
Ohba A, Morizane C, Kawamoto Y, Komatsu Y, Ueno M, Kobayashi S, Ikeda M,Sasaki M, Furuse J, et al. |
J ClinOncol. 2024 Sep 20;42(27):3207-3217. doi: 10.1200/JCO.23.02010. Epub 2024 Aug 5.PMID: 39102634; PMCID: PMC11404765. |
| NCC |
39089862 |
2024 |
Dynamics of the gut microbiome in FAP patients undergoing intensive endoscopic reduction of polyp burden. |
Mizutani S, Tamaki A, Shiba S, Salim F, Yamada M, Takamaru H, Nakajima T, Yoshida N, Ikuta S, et al. |
Gut. 2024 Aug 1:gutjnl-2024-332381. doi: 10.1136/gutjnl-2024-332381. Online ahead of print. |
| NCC |
39069202 |
2024 |
Heterogeneity or change in cell oforigin in diffuse large B-cell lymphomas determined using hans algorithm. |
Maeshima AM, Taniguchi H, Takahashi Y, Kaimi Y, Ochi T, Makino H, Makita S,Iwaki N, Fukuhara S, et al. |
Hum Pathol. 2024 Sep;151:105630. doi: 10.1016/j.humpath.2024.105630. Epub 2024 Jul26. PMID: 39069202. |
| NCC |
39056535 |
2024 |
Kaimi Y, Naka T, Yoshida H, Uno M, Maeshima AM. Histopathology of peritonitisdue to infectious mononucleosis with background Chlamydia trachomatis infection:A case report and literature review. Pathol Int. 2024 Jul 26. doi:10.1111/pin.13469. Epub ahead of print. PMID: 39056535. |
Kaimi Y, Naka T, Yoshida H, Uno M, Maeshima AM. |
Pathol Int. 2024 Jul 26. doi:10.1111/pin.13469. Epub ahead of print. PMID: 39056535. |
| NCC |
38970674 |
2024 |
MUC5AC immunoreactivity in scattered tumor cells is useful for diagnosing CIC-rearranged sarcoma. |
Nishino S, Kojima N, Sugino H, Mori T, Yatabe Y, Yoshida A. |
Virchows Arch. 2024 Aug;485(2):359-363. doi:10.1007/s00428-024-03863-z. Epub 2024 Jul 6. PMID: 38970674. |
| NCC |
38947747 |
2024 |
Diagnostic performance of EUS-guided tissue acquisition for solid pancreaticlesions ≤10 mm. |
Kawasaki Y, Hijioka S, Nagashio Y, Ohba A, Maruki Y, Takeshita K, Takasaki T,Agarie D, Hagiwara Y, et al. |
Endosc Ultrasound. 2024 Mar-Apr;13(2):115-122. doi:10.1097/eus.0000000000000052. Epub 2024 Apr 5. PMID: 38947747; PMCID:PMC11213607. |
| NCC |
38945375 |
2024 |
Clinicopathological differencesbetween T-lymphoblastic leukemia/lymphoma, early T-precursor lymphoblasticleukemia/lymphoma, and mixed-phenotype acute leukemia with T lineage: Ananalysis of 41 adult cases. |
Takahashi Y, Kaimi Y, Taniguchi H, Ochi T, Makino H, Makita S, Iwaki N,Fukuhara S, Munakata W, et al. |
Hum Pathol. 2024 Aug;150:78-85. doi:10.1016/j.humpath.2024.06.016. Epub 2024 Jun 28. PMID: 38945375. |
| NCC |
38936102 |
2024 |
Prognostic value of the international association for the study of lung cancer grading system and its association with the tumor microenvironment in stage I EGFR-muted lung adenocarcinoma. |
Kubota S, Taki T, Miyoshi T, Tane K, Samejima J, Aokage K, Wakabayashi M, Nomura K, Nagamine M, et al. |
Eur J Cancer. 2024 Aug:207:114184. doi: 10.1016/j.ejca.2024.114184. Epub 2024 Jun 24. |
| NCC |
38927897 |
2024 |
Immunohistochemical Profiling of SSTR2 and HIF-2α with theTumor Microenvironment in Pheochromocytoma and Paraganglioma. |
Uchihara M, Tanabe A, Kojima Y, Shimoi T, Maeshima AM, Umamoto K, ShimomuraA, Shimizu C, Yamazaki Y, et al. |
Cancers (Basel).2024 Jun 11;16(12):2191. doi: 10.3390/cancers16122191. PMID: 38927897; PMCID:PMC11201597. |
| NCC |
38914166 |
2024 |
Prognostic significance of micronest in cancer stroma in resected lung squamous cell carcinoma. |
Kaminuma Y, Nakai T, Aokage K, Taki T, Miyoshi T, Tane K, Samejima J, Miyazaki S, Sakamoto N, et al. |
Hum Pathol. 2024 Aug:150:20-28. doi: 10.1016/j.humpath.2024.06.010. Epub 2024 Jun 22. |
| NCC |
38864517 |
2024 |
Long-Term Outcomes of Additional Surgery After Endoscopic Resection Versus Primary Surgery for T1 Colorectal Cancer |
Tamaru Y, Kuwai T, Kajiwara Y, Oka S, Saito S, Fukunaga Y, Kawachi H, Takamatsu M, Hotta K, et al. |
Am J Gastroenterol 2024 Jun 12. doi: 10.14309/ajg.0000000000002879. Online ahead of print. 2024 |
| NCC |
38846982 |
2024 |
Efficacy of anti-PD-1 monotherapy for recurrent or metastatic olfactory neuroblastoma. |
Hoshi Y, Enokida T, Tamura S, Nakashima T, Okano S, Fujisawa T, et al. |
Front Oncol. 2024;14:1379013. |
| NCC |
38844774 |
2024 |
Genomic profiles of Japanese patients with vulvar squamous cell carcinoma. |
Fujii E, Kato MK, Yamaguchi M, Higuchi D, Koyama T, Komatsu M, Hamamoto R, Ishikawa M, Kato T, et al. |
Sci Rep. 2024 Jun 6;14(1):13058. |
| NCC |
38824688 |
2024 |
Aberrant cell adhesiveness due to DNAhypermethylation of KLF11 in papillary urothelial carcinomas. |
Tsumura K, Fujimoto M, Tian Y, Kawahara T, Fujimoto H, Maeshima AM, NakagawaT, Kume H, Yoshida T, et al. |
Exp Mol Pathol.2024 Jun;137:104908. doi: 10.1016/j.yexmp.2024.104908. Epub 2024 Jun 1. PMID:38824688. |
| NCC |
38811497 |
2024 |
Clinical and Pathologic Differences between Small-Cell Carcinoma and Large-Cell Neuroendocrine Carcinoma of the Lung. Ann Surg Oncol. |
Fujiwara W, Yotsukura M, Yoshida Y, Nakagawa K, Kashima J, Yatabe Y, WatanabeSI. |
Ann Surg Oncol. 2024Sep;31(9):5697-5705. doi: 10.1245/s10434-024-15505-4. Epub 2024 May 29. PMID:38811497. |
| NCC |
38805901 |
2024 |
Clinicopathological differences between EGFR mutated and EGFR wild-type lung adenocarcinoma with papillary predominant pattern. |
Goto E, Taki T, Nomura K, Miyakami Y, Miyoshi T, Tane K, Samejima J, Aokage K, Nagamine M, et al. |
Lung Cancer. 2024 Jun:192:107830. doi: 10.1016/j.lungcan.2024.107830. Epub 2024 May 23. |
| NCC |
38725237 |
2024 |
Unveiling pembrolizumab effectiveness in diverse subtypes of MSI-high endometrial cancers. |
Ozawa R, Nishikawa T, Yoshida H, Shiraishi K, Shimoi T, Kato T, Yonemori K. |
J Gynecol Oncol 2024 May. Online ahead of print. |
| NCC |
38706977 |
2024 |
Rapid Response to Lenvatinib and Disease Flare After Discontinuation in a Patient With Thymic Carcinoma Harboring KIT Exon 11 Mutation: A Case Report. |
Torasawa M, Yoshida T, Shiraishi K, Goto N, Ueno T, Ichikawa H, Yagishita S, Kohsaka S, Goto Y, et al. |
JTO clinical and research reports |
| NCC |
38693263 |
2024 |
Geographic variation of mutagenic exposures in kidney cancer genomes. |
Senkin S, Moody S, Díaz-Gay M, Abedi-Ardekani B, Cattiaux T, Ferreiro-Iglesias A, Wang J, Fitzgerald S, Kazachkova M, et al. |
Nature. 2024 May;629(8013):910-918. doi: 10.1038/s41586-024-07368-2. Epub 2024 May 1. |
| NCC |
38692808 |
2024 |
Sarcoma of the Lung and Mediastinum. |
Yoshida KI, Yoshida A. |
Surgical pathology clinics |
| NCC |
38679860 |
2024 |
Feasibility of multimodal therapy for rhabdomyosarcoma in a patient with Fukuyama congenital muscular dystrophy. |
Sugiyama M, Arakawa A, Iwata S, Tao K, Shirakawa N, Watanabe Y, Nakajima M, Yoshida A, Ishigaki K, et al. |
Pediatric blood & cancer |
| NCC |
38679686 |
2024 |
Impact of Surgical Margin Status on Survival and Recurrence AfterPancreaticoduodenectomy for Distal Cholangiocarcinoma: Is Microscopic ResidualTumor (R1) Associated with Higher Rates of Local Recurrence? |
Umino R, Nara S, Mizui T, Takamoto T, Ban D, Esaki M, Hiraoka N, Shimada K. |
Ann Surg Oncol.2024 Aug;31(8):4910-4921. doi: 10.1245/s10434-024-15313-w. Epub 2024 Apr 28.PMID: 38679686. |
| NCC |
38651188 |
2024 |
Potential utility of pretreatment serum miRNAs for optimal treatment selection in advanced high-grade serous ovarian cancer Jpn |
Uehara T, Matsuzaki J, Yoshida H, Ogawa Y, Miura J, Fujimiya H, Yamamoto Y, Kawauchi J, Takizawa S, et al. |
J Clin Oncol 54(8):917-925. 2024 |
| NCC |
38593478 |
2024 |
Clinical significance of inter-assay discrepancy in PD-L1 evaluation for the efficacy of pembrolizumab in advanced NSCLC with high PD-L1 expression. |
Miyakoshi J, Yoshida T, Kashima J, Shirasawa M, Torasawa M, Matsumoto Y, Masuda K, Shinno Y, Okuma Y, et al. |
Lung Cancer. 2024 May;191:107788. |
| NCC |
38590413 |
2024 |
CRP and soluble CTLA4 are determinants of anti-PD1 resistance in gastrointestinal cancer. |
Oshima K, Shoji H, Boku N, Hirano H, Okita N, Takashima A, Kato K, Kudo-Saito C. |
American journal of cancer research |
| NCC |
38584451 |
2024 |
Genomic and Pathologic Profiling of Very Well-Differentiated Gastric Adenocarcinoma of Intestinal Type: A Study With Emphasis on Diffuse-Type Transformation. |
Rokutan H, Arai Y, Kunita A, Yamasaki S, Nakamura H, Hama N, Nakayama A, Hosoda F, Totoki Y, et al. |
Am J Surg Pathol. 2024 Jun 1;48(6):652-661. doi: 10.1097/PAS.0000000000002222. Epub 2024 Apr 8. |
| NCC |
38565653 |
2024 |
An algorithm-based technique for counting mitochondria in cells using immunohistochemical staining of formalin-fixed and paraffin-embedded sections. |
Sakashita M, Motoi N, Yamamoto G, Gambe E, Suzuki M, Yoshida Y, Watanabe SI, Takazawa Y, Aoki K, et al. |
J Cancer Res Clin Oncol. 2024 Apr 3;150(4):172. doi: 10.1007/s00432-024-05653-1. |
| NCC |
38563834 |
2024 |
Tumor-InfiltratingLymphocytes in Triple-Negative Breast Cancer. |
Leon-Ferre RA, Jonas SF, Salgado R, Loi S, de Jong V, Carter JM, Nielsen TO,Leung S, Riaz N, et al. |
JAMA. 2024 Apr2;331(13):1135-1144. doi: 10.1001/jama.2024.3056. PMID: 38563834; PMCID:PMC10988354. |
| NCC |
38557577 |
2024 |
FDG PET/CT and MRI Findings of Extraskeletal Myxoid Chondrosarcoma Showing a Nonmyxoid Cellular Variant. |
Hirasawa M, Kikuchi Y, Sato K, Yoshida A, Yamamoto A. |
Clinical nuclear medicine |
| NCC |
38527308 |
2024 |
Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments. |
Fukuda H, Arai K, Mizuno H, Nishito Y, Motoi N, Arai Y, Hiraoka N, Shibata T, Sonobe Y, et al. |
Cancer Sci. 2024 Jun;115(6):1763-1777. doi: 10.1111/cas.16154. Epub 2024 Mar 25. |
| NCC |
38478355 |
2024 |
Establishment and characterization of NCC-ASPS2-C1: a novel patient-derived cell line of alveolar soft part sarcoma. |
Osaki J, Noguchi R, Yanagihara K, Ono T, Adachi Y, Iwata S, Toda Y, Sekita T, Kobayashi E, et al. |
Human cell |
| NCC |
38466561 |
2024 |
Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1. |
Adachi Y, Noguchi R, Yoshimatsu Y, Sin Y, Osaki J, Ono T, Iwata S, Akiyama T, Tsuchiya R, et al. |
Human cell |
| NCC |
38459590 |
2024 |
Spatial intratumor heterogeneity of programmed death-ligand 1 expression predicts poor prognosis in resected non-small cell lung cancer |
Nagasaki Y, Taki T, Nomura K, Tane K, Miyoshi T, Samejima J, Aokage K, Ohtani-Kim SJ, Kojima M, et al. |
J Natl Cancer Inst 2024 Jul 1;116(7):1158-1168. doi: 10.1093/jnci/djae053. 2024 |
| NCC |
38433331 |
2024 |
Clinical feartures and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer. |
Kato MK, Fujii E, Asami Y, Momozawa Y, Hiranuma K, Komatsu M, Hamamoto R, Ebata T, Matsumoto K, et al. |
Cancer Sci. 2024 May;115(5):1646-1655. |
| NCC |
38433247 |
2024 |
Advances in cancer DNA methylation analysis with methPLIER: use of non-negative matrix factorization and knowledge-based constraints to enhance biological interpretability. |
Takasawa K, Asada K, Kaneko S, Shiraishi K, Machino H, Takahashi S, Shinkai N, Kouno N, Kobayashi K, et al. |
Experimental & molecular medicine |
| NCC |
38429077 |
2024 |
Pooled Analysis of Pralatrexate Single-Agent Studies in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma. |
O’Connor OA, Ko BS, Wang MC, Maruyama D, Song Y, Yeoh EM, Manamley N, Tobinai K. |
Blood advances |
| NCC |
38409909 |
2024 |
Harnessing the potential of reverse-phase protein array technology: Advancing precision oncology strategies. |
Masuda M, Nakagawa R, Kondo T. |
Cancer science |
| NCC |
38402356 |
2024 |
Extracting interpretable features for pathologists using weakly supervised learning to predict p16 expression in oropharyngeal cancer. |
Adachi M, Taki T, Sakamoto N, Kojima M, Hirao A, Matsuura K, Hayashi R, Tabuchi K, Ishikawa S, et al. |
Sci Rep. 2024 Feb 24;14(1):4506. doi: 10.1038/s41598-024-55288-y. |
| NCC |
38388856 |
2024 |
Age at lung cancer diagnosis in females versus males who never smoke by race and ethnicity. |
Blechter B, Wong JYY, Chien LH, Shiraishi K, Shu XO, Cai Q, Zheng W, Ji BT, Hu W, et al. |
British journal of cancer |
| NCC |
38382595 |
2024 |
Passive Smoking-Induced Mutagenesis as a Promoter of Lung Carcinogenesis. |
Mochizuki A, Shiraishi K, Honda T, Higashiyama RI, Sunami K, Matsuda M, Shimada Y, Miyazaki Y, Yoshida Y, et al. |
Journal of thoracic oncology |
| NCC |
38372888 |
2024 |
Establishment and characterization of NCC-DFSP5-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line. |
Ono T, Noguchi R, Osaki J, Akiyama T, Adachi Y, Kojima N, Toda Y, Fukushima S, Yoshimatsu Y, et al. |
Hum Cell. 2024 Feb 19. |
| NCC |
38368425 |
2024 |
Assessing the efficacy of target adaptive sampling long-read sequencing through hereditary cancer patient genomes. |
Nakamura W, Hirata M, Oda S, Chiba K, Okada A, Mateos RN, Sugawa M, Iida N, Ushiama M, et al. |
NPJ Genom Med. 2024 Feb 17;9(1):11. doi:10.1038/s41525-024-00394-z. PMID: 38368425. |
| NCC |
38363490 |
2024 |
The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma. |
Shirai Y, Ueno T, Kojima S, Ikeuchi H, Kitada R, Koyama T, Takahashi F, Takahashi K, Ichimura K, et al. |
Journal of neuro-oncology |
| NCC |
38358935 |
2024 |
2021 WHO Classification of Lung Cancer: Molecular Biology Research and Radiologic-Pathologic Correlation. |
Sasaki T, Kuno H, Hiyama T, Oda S, Masuoka S, Miyasaka Y, Taki T, Nagasaki Y, Ohtani-Kim SJ, et al. |
Radiographics. 44(3):e230136 |
| NCC |
38353696 |
2024 |
MAP1B-cortactin-Tks5 axis regulates TNBC invasion and tumorigenesis. |
Inoue H, Kanda T, Hayashi G, Munenaga R, Yoshida M, Hasegawa K, Miyagawa T,Kurumada Y, Hasegawa J, et al. |
Journal of Cell BiologyBiol. 2024 Mar 4;223(3):e202303102. doi: 10.1083/jcb.202303102. Epub 2024 Feb14. PMID: 38353696; PMCID: PMC10866687. |
| NCC |
38349387 |
2024 |
Loss of or decrease in CD30 expression in four patients with anaplastic large cell lymphoma after brentuximab vedotin-containing therapy. |
Kaimi Y, Takahashi Y, Taniguchi H, Ochi T, Makino H, Makita S, Iwaki N, Fukuhara S, Munakata W, et al. |
Virchows Arch. 2024 Feb 13. doi:10.1007/s00428-024-03764-1. Epub ahead of print. PMID: 38349387. |
| NCC |
38336371 |
2024 |
Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancer. |
Takei S, Tanaka Y, Lin YT, Koyama S, Fukuoka S, Hara H, Nakamura Y, Kuboki Y, Kotani D, et al. |
J Immunother Cancer. 2024 Feb 8;12(2):e008210. doi: 10.1136/jitc-2023-008210. PMID: 38336371; PMCID: PMC10860060. |
| NCC |
38332448 |
2024 |
Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for gliomas. |
Takuma Nakashima, Ryo Yamamoto, Makoto Ohno, Hirokazu Sugino, Masamichi Takahashi, Yusuke Funakoshi, Shohei Nambu, Atsuhito Uneda, Shunsuke Yanagisawa, et al. |
Brain Tumor Pathology, April;41(2), 2024. |
| NCC |
38325367 |
2024 |
The Mutographs biorepository: A unique genomic resource to study cancer around the world. |
Perdomo S, Abedi-Ardekani B, de Carvalho AC, Ferreiro-Iglesias A, Gaborieau V, Cattiaux T, Renard H, Chopard P, Carreira C, et al. |
Cell Genom. 2024 Jan 31:100500. doi: 10.1016/j.xgen.2024.100500. Online ahead of print. |
| NCC |
38319510 |
2024 |
EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system. |
Nomura K, Aokage K, Kaminuma Y, Nakai T, Wakabayashi M, Ikeno T, Koike Y, Taki T, Miyoshi T, et al. |
Int J Clin Oncol. Online ahead of print. |
| NCC |
38308036 |
2024 |
Is 18F-fluorodeoxyglucose PET recommended for small lung nodules? CT findings of 18F-fluorodeoxyglucose non-avid lung cancer. |
Sugawara H, Kikkawa N, Ito K, Watanabe H, Kaku S, Akai H, Abe O, Watanabe SI, Yatabe Y, et al. |
Br J Radiol. 2024 Feb 2;97(1154):462-468. doi: 10.1093/bjr/tqad048. PMID: 38308036. |
| NCC |
38284990 |
2024 |
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. |
Qin Z, Yue M, Tang S, Wu F, Sun H, Li Y, Zhang Y, Izumi H, Huang H, et al. |
J Exp Med. 221(3):e20232028 |
| NCC |
38281442 |
2024 |
Survival outcome of patient with pT1N0 biliary tract cancer treated with surgery alone. |
Kagoura M, Kobayashi S, Kojima M, Kudo M, Sugimoto M, Konishi M, Gotohda N. |
Eur J Surg Oncol. 50(3):107980, Online ahead of print. |
| NCC |
38217368 |
2024 |
Congenital dermatofibrosarcoma protuberans on the scalp enlarging and shrinking repeatedly. |
Wada S, Nakano E, Nakajima M, Kishikawa S, Yoshida A, Mori T, Osada A, Ogata D, Namikawa K, et al. |
J Dermatol. 2024 Jan 13. doi: 10.1111/1346-8138.17094. Epub ahead of print. PMID: 38217368. |
| NCC |
38183216 |
2024 |
Ten-year follow-up outcomes of limited resection trial for radiologically less-invasive lung cancer. |
Niimi T, Samejima J, Wakabayashi M, Miyoshi T, Tane K, Aokage K, Taki T, Nakai T, Ishii G, et al. |
Jpn J Clin Oncol. Online ahead of print. |
| NCC |
38172491 |
2024 |
Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer. |
Ohashi K, Nishito Y, Fukuda H, Sadahiro R, Yoshida Y, Watanabe SI, Motoi N, Sonobe Y, Mizuno H, et al. |
Scientific reports |
| NCC |
38160515 |
2024 |
Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutation. |
Kitagawa S, Zenke Y, Taki T, Aokage K, Sakai T, Shibata Y, Izumi H, Nosaki K, Umemura S, et al. |
Lung Cancer. 188:107453 |
| NCC |
38143259 |
2024 |
Establishment and characterization of NCC-PMP2-C1: a novel patient-derived cell line of pseudomyxoma peritonei with signet ring cells. |
Noguchi R, Yoshimatsu Y, Sin Y, Ono T, Tsuchiya R, Yoshida H, Kiyono T, Yonemura Y, Kondo T. |
Human cell |
| NCC |
37952098 |
2024 |
Rare but clinically important salivary gland-type tumor of the lung: Areview. |
Takamori S, Yatabe Y, Osoegawa A, Aokage K, Yoshioka H, Miyoshi T, Mimae T, Endo M, Hattori A, et al. |
Jpn J Clin Oncol. 2024 Feb 7;54(2):121-128. doi: 10.1093/jjco/hyad154.PMID: 37952098. |
| NCC |
37936491 |
2024 |
Molecular pathology of non-small cell carcinoma. |
Yatabe Y. |
Histopathology. 2024 Jan;84(1):50-66. doi: 10.1111/his.15080. Epub 2023 Nov 7. PMID: 37936491. |
| NCC |
37914528 |
2024 |
Mesothelin expression in gynecologic carcinosarcoma: clinicopathological significance and correlation with HER2 expression. |
Kitadai R, Nishikawa T, Yoshida H, Mizoguchi C, Yamamoto K, Kato T, Yonemori K. |
J Gynecol Oncol. 2024 Mar;35(2):e11. doi: 10.3802/jgo.2024.35.e11. Epub 2023 Oct 12. |
| NCC |
37907774 |
2024 |
Establishment and characterization of NCC-LMS3-C1: a novel patient-derived cell line of leiomyosarcoma. |
Yoshimatsu Y, Noguchi R, Osaki J, Sin Y, Tsuchiya R, Ono T, Akiyama T, Adachi Y, Tanzawa Y, et al. |
Human cell |
| NCC |
37882647 |
2024 |
Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome-wide association and whole genome sequencing analyses. |
Shiraishi K, Takahashi A, Momozawa Y, Daigo Y, Kaneko S, Kawaguchi T, Kunitoh H, Matsumoto S, Horinouchi H, et al. |
Cancer Commun (Lond). 2024 Feb;44(2):287-293. doi: 10.1002/cac2.12498. Epub 2023 Oct 26. PMID: 37882647. |
| NCC |
37871654 |
2024 |
Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases. Mod Pathol. 2024 Jan;37(1):100359. doi: 10.1016/j.modpat.2023.100359. Epub 2023 Oct 21. PMID: 37871654. |
Odate T, Satomi K, Kubo T, Matsushita Y, Ueno T, Kurose A, Shomori K, Nakai T, Watanabe R, et al. |
Mod Pathol. 2024 Jan;37(1):100359. doi: 10.1016/j.modpat.2023.100359. Epub 2023 Oct 21. PMID: 37871654. |
| NCC |
37843666 |
2024 |
ASO Visual Abstract: Impact of 18F-FDG PET on TNM Staging and Prognosis in Thymic Epithelial Tumors. |
Akamine T, Nakagawa K, Ito K, Watanabe H, Yotsukura M, Yoshida Y, Yatabe Y, Kusumoto M, Watanabe SI. |
Ann Surg Oncol. 2024 Feb;31(2):1146-1147. doi: 10.1245/s10434-023-14391-6. PMID: 37843666. |
| NCC |
37815156 |
2024 |
Use of clinical variables for preoperative prediction of lymph node metastasis in endometrial cancer. |
Ueno Y, Yoshida E, Nojiri S, Kato T, Ohtsu T, Takeshita T, Suzuki S, Yoshida H, Kato K, et al. |
Jpn J Clin Oncol. 2024 Jan 7;54(1):38-46. doi: 10.1093/jjco/hyad135. PMID: 37815156; PMCID: PMC10773201. |
| NCC |
37779063 |
2024 |
Two Cases of Disseminated AlveolarEchinococcosis: The Diagnosis, Management, and Differential Considerations forLiver Lesions. |
Hirano K, Maruki Y, Yamashige D, Kobayashi O, Shiotsuka M, Morizane C,Imamura T, Hiraoka N, Okusaka T. |
Intern Med. 2024 May 1;63(9):1247-1252. doi:10.2169/internalmedicine.2444-23. Epub 2023 Sep 29. PMID: 37779063; PMCID:PMC11116014. |
| NCC |
37751933 |
2024 |
Precancerous nature of intestinal metaplasia with increased chance of conversion and accelerated DNA methylation. |
Takeuchi C, Yamashita S, Liu YY, Takeshima H, Sasaki A, Fukuda M, Hashimoto T, Naka T, Ishizu K, et al. |
Gut. 2024 Jan 5;73(2):255-267. doi: 10.1136/gutjnl-2023-329492. PMID: 37751933. |
| NCC |
37717856 |
2024 |
Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment. |
Dacic S, Cao X, Bota-Rabassedas N, Sanchez-Espiridion B, Berezowska S, Han Y, Chung JH, Beasley MB, Dongmei L, et al. |
J Thorac Oncol. 2024 Feb;19(2):273-284. doi: 10.1016/j.jtho.2023.09.275. Epub 2023 Sep 16. PMID:37717856. |
| NCC |
37704823 |
2024 |
Kojima N, Kubo T, Mori T, Satomi K, Matsushita Y, Iwata S, Yatabe Y, Ichimura K, Kawai A, Ichikawa H, Yoshida A. Myxoid liposarcoma with nuclear pleomorphism: a clinicopathological and molecular study. Virchows Arch. 2024 Jan;484(1):71-81. doi: 10.1007/s00428-023-03631-5. Epub 2023 Sep 13. PMID: 37704823. |
Kojima N, Kubo T, Mori T, Satomi K, Matsushita Y, Iwata S, Yatabe Y, Ichimura K, Kawai A, et al. |
Virchows Arch. 2024 Jan;484(1):71-81. doi: 10.1007/s00428-023-03631-5. Epub 2023 Sep 13. PMID: 37704823. |
| NCC |
37612088 |
2024 |
Clinicopathological Findings and Treatment Outcomes ofPatients with Primary Hepatobiliary Neuroendocrine Neoplasms: A RetrospectiveSingle-institution Analysis. |
Komiyama S, Okusaka T, Maruki Y, Ohba A, Nagashio Y, Kondo S, Hijioka S,Morizane C, Ueno H, et al. |
Intern Med. 2024 Apr 1;63(7):891-901. doi:10.2169/internalmedicine.2016-23. Epub 2023 Aug 23. PMID: 37612088; PMCID:PMC11045373. |
| NCC |
37596787 |
2024 |
Activated Akt expression is associated with the recurrence of primary melanomas and further refines the prognostic and predictive values for relapse in acral melanomas. |
Nojima K, Hayashi M, Tanemura A, Al-Busani H, Saito T, Suzuki T, Ishikawa M, Mori T, Wada S, et al. |
Pigment Cell Melanoma Res. 2024 Jan;37(1):36-44. doi:10.1111/pcmr.13119. Epub 2023 Aug 18. PMID: 37596787. |
| NCC |
38133797 |
2023 |
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation. |
Nakata S, Arai Y, Fukuoka K, Shirakura T, Yamazaki A, Osawa S, Hama N, Shibata T, Miyagishima T, et al. |
Brain Tumor Pathol. 2024 Jan;41(1):35-39. doi: 10.1007/s10014-023-00475-4. Epub 2023 Dec 22. |
| NCC |
38104198 |
2023 |
Genomic and epigenomic integrative subtypes of renal cell carcinoma in a Japanese cohort. |
Fukagawa A, Hama N, Totoki Y, Nakamura H, Arai Y, Saito-Adachi M, Maeshima A, Matsui Y, Yachida S, et al. |
Nat Commun. 2023 Dec 16;14(1):8383. doi: 10.1038/s41467-023-44159-1. PMID: 38104198; PMCID: PMC10725467. |
| NCC |
38102134 |
2023 |
Whole-genome sequencing reveals the molecular implications of the stepwise progression of lung adenocarcinoma. |
Haga Y, Sakamoto Y, Kajiya K, Kawai H, Oka M, Motoi N, Shirasawa M, Yotsukura M, Watanabe SI, et al. |
Nat Commun. 14(1):8375, 2023 doi: 10.1038/s41467-023-43732-y. PMID: 38102134; PMCID: PMC10724178. |
| NCC |
38091397 |
2023 |
Comprehensive single-cell analysis demonstrates radiotherapy-induced infiltration of macrophages expressing immunosuppressive genes into tumor in esophageal squamous cell carcinoma. |
Oyoshi H, Du J, Sakai SA, Yamashita R, Okumura M, Motegi A, Hojo H, Nakamura M, Hirata H, et al. |
Sci Adv. 2023 Dec 15;9(50):eadh9069. doi: 10.1126 |
| NCC |
38071343 |
2023 |
Promoter swapping of truncated PDGFRB drives Ph-like acute lymphoblastic leukemia. |
Miyazaki B, Ueno T, Sugiyama M, Kojima S, Arakawa A, Tao K, Tanimura K, Shiraishi K, Yagishita S, et al. |
NPJ Precis Oncol. 2023 Dec 9;7(1):132. doi: 10.1038/s41698-023-00485-7. |
| NCC |
38054200 |
2023 |
Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinoma. |
Kojima Y, Yoshida H, Okuya T, Okuma HS, Nishikawa T, Tanioka M, Sudo K, Noguchi E, Shimoi T, et al. |
Gynecol Oncol Rep. 2023 Nov 14;50:101302. doi: 10.1016/j.gore.2023.101302. PMID: 38054200; PMCID: PMC10694048. |
| NCC |
38043787 |
2023 |
Correlation of Vein-Rich Tumor Microenvironment of Intrahepatic Cholangiocarcinoma With Tertiary Lymphoid Structures and Patient Outcome. |
Doi N, Ino Y, Fuse M, Esaki M, Shimada K, Hiraoka N. |
Mod Pathol. 2023 Dec 1;37(2):100401. doi: 10.1016/j.modpat.2023.100401. Epub ahead of print. PMID: 38043787. |
| NCC |
38018800 |
2023 |
High-grade intraductal carcinoma of the parotid gland harboring CTNNA1::ALK rearrangement: Changes in genetic status using genetic testing during treatment with an ALK inhibitor. |
Watanabe T, Honma Y, Yonemori K, Sunami K, Yoshimoto S, Mori T. |
Head Neck. 2024 Mar;46(3):E26-E31. doi: 10.1002/hed.27587. Epub 2023 Nov 29. PMID: 38018800. |
| NCC |
37965425 |
2023 |
Strategic Approach to Heterogeneity Analysis of Cutaneous Adnexal Carcinomas Using Computational Pathology and Genomics. |
Nishimura Y, Ryo E, Inoue S, Kawazu M, Ueno T, Namikawa K, Takahashi A, Ogata D, Yoshida A, et al. |
JID Innov. 2023 Sep 9;3(6):100229. doi:10.1016/j.xjidi.2023.100229. PMID: 37965425; PMCID: PMC10641284. |
| NCC |
37957137 |
2023 |
Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists. |
Kerr KM, Bubendorf L, Lopez-Rios F, Khalil F, Roy-Chowdhuri S, Joubert P, Hartmann A, Guerini-Rocco E, Yatabe Y, et al. |
Histopathology. 2024 Feb;84(3):429-439. doi:10.1111/his.15078. Epub 2023 Nov 13. PMID: 37957137. |
| NCC |
37952045 |
2023 |
Prognostic impact of HER2-low positivity in patients with HR-positive, HER2-negative, node-positive early breast cancer. |
Shikata S, Murata T, Yoshida M, Hashiguchi H, Yoshii Y, Ogawa A, Watase C, Shiino S, Sugino H, et al. |
Sci Rep. 2023 Nov 11;13(1):19669. doi: 10.1038/s41598-023-47033-8. PMID: 37952045; PMCID:PMC10640570. |
| NCC |
37927931 |
2023 |
Hayashi T, Takasawa K, Yoshikawa T, Hashimoto T, Sekine S, Wada T, Yamagata Y, Suzuki H, Abe S, Yoshinaga S, Saito Y, Kouno N, Hamamoto R. A discrimination model by machine learning to avoid gastrectomy for early gastric cancer. Ann Gastroenterol Surg. 2023 Jul 13;7(6):913-921. doi: 10.1002/ags3.12714. PMID:37927931; PMCID: PMC10623978. |
Hayashi T, Takasawa K, Yoshikawa T, Hashimoto T, Sekine S, Wada T, Yamagata Y, Suzuki H, Abe S, et al. |
Ann Gastroenterol Surg. 2023 Jul 13;7(6):913-921. doi: 10.1002/ags3.12714. PMID:37927931; PMCID: PMC10623978. |
| NCC |
37923915 |
2023 |
Correction: Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer. |
Shirasawa M, Yoshida T, Shiraishi K, Goto N, Yagishita S, Imabayashi T, Matsumoto Y, Masuda K, Shinno Y, et al. |
British journal of cancer |
| NCC |
37906571 |
2023 |
DNA methylation alterations of ADCY5,MICAL2, and PLEKHG2 during the developmental stage of cryptogenic hepatocellular carcinoma. |
Makiuchi S, Tian Y, Fujimoto M, Kuramoto J, Tsuda N, Ojima H, Gotoh M,Hiraoka N, Yoshida T, et al. |
Hepatol Res. 2023 Oct 31. doi: 10.1111/hepr.13984. Epub ahead of print. PMID: 37906571. |
| NCC |
37881128 |
2023 |
Correlation between L-amino acid transporter 1expression and 4-borono-2-18 F-fluoro-phenylalanine accumulation in humans. |
Kashihara T, Mori T, Nakaichi T, Nakamura S, Ito K, Kurihara H, Kusumoto M, Itami J, Yoshimoto S, et al. |
Cancer Med. 2023 Nov;12(21):20564-20572. doi: 10.1002/cam4.6635. Epub 2023 Oct 25. PMID: 37881128; PMCID: PMC10660410. |
